Cargando…

Cardiac Resynchronization Therapy for Transthyretin Cardiac Amyloidosis

Detalles Bibliográficos
Autores principales:	Donnellan, Eoin, Wazni, Oussama M., Hanna, Mazen, Kanj, Mohamed, Saliba, Walid I., Jaber, Wael A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660724/ https://www.ncbi.nlm.nih.gov/pubmed/32633203 http://dx.doi.org/10.1161/JAHA.120.017335

Ejemplares similares

Electrophysiological Manifestations of Cardiac Amyloidosis: JACC: CardioOncology State-of-the-Art Review
por: Hartnett, Jack, et al.
Publicado: (2021)

Subthreshold Aortic Valve Calcium Scores in Severe Aortic Stenosis and Transthyretin Cardiac Amyloidosis
por: Hussain, Muzna, et al.
Publicado: (2020)

Transthyretin cardiac amyloidosis
por: Tomoaia, Raluca, et al.
Publicado: (2021)

Transthyretin cardiac amyloidosis
por: Porcari, Aldostefano, et al.
Publicado: (2022)

Deleterious effect of right ventricular pacing in patients with cardiac transthyretin amyloidosis: potential clinical benefit of cardiac resynchronization therapy
por: Aouate, David, et al.
Publicado: (2020)

Analysis of cardiac motion without respiratory motion for cardiac stereotactic body radiation therapy
por: Ouyang, Zi, et al.
Publicado: (2020)

Evidence of Concurrent Light Chain and Transthyretin Cardiac Amyloidosis in 2 Patients
por: Donnelly, Joseph P., et al.
Publicado: (2020)

Cardiovascular outcomes after cardiac resynchronization therapy in cardiac amyloidosis
por: Fischer, Kilian, et al.
Publicado: (2021)

Imaging modalities in early cardiac transthyretin amyloidosis: who is first?
por: Ney, Svenja, et al.
Publicado: (2022)

Transthyretin Cardiac Amyloidosis: Underrecognized in the Underrepresented
por: Leedy, Douglas J., et al.
Publicado: (2023)

Left Bundle Branch Pacing in Transthyretin Cardiac Amyloidosis and Alternating Bundle Branch Block
por: Ahmed, Taha, et al.
Publicado: (2020)

Atrial fibrillation catheter ablation complications in obese and diabetic patients: Insights from the US Nationwide Inpatient Sample 2005–2013
por: D'Souza, Shawn, et al.
Publicado: (2021)

The Added Value of Preprocedural Cardiac Computed Tomography in Planning Left Atrial Appendage Closure With the Watchman FLX Device
por: Kassab, Joseph, et al.
Publicado: (2023)

Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage
por: Law, Steven, et al.
Publicado: (2020)

Transthyretin cardiac amyloidosis: an update on diagnosis and treatment
por: Yamamoto, Hiroyuki, et al.
Publicado: (2019)

The Role of Imaging in Diagnosing Transthyretin Cardiac Amyloidosis
por: Chaaban, Nourhan, et al.
Publicado: (2021)

Cardiac Transthyretin Amyloidosis: Hidden in Plain Sight
por: Logothetis, Constantine N., et al.
Publicado: (2021)

Spontaneous intramyocardial haematoma in transthyretin cardiac amyloidosis
por: Parizher, Gary, et al.
Publicado: (2022)

Risk stratification in transthyretin-related cardiac amyloidosis
por: Scirpa, Riccardo, et al.
Publicado: (2023)

Multimodality Imaging for Diagnosing Transthyretin Cardiac Amyloidosis
por: Palot Manzil, Fathima Fijula, et al.
Publicado: (2023)

Estimating nuclear scanning capacity requirements for patients with suspected cardiac transthyretin amyloidosis
por: Leo, Vincenzo C., et al.
Publicado: (2023)

Atypical Case of Wild-Type Cardiac Amyloidosis with Septal Predominance and a Nonapical Sparing Strain Pattern
por: Hussain, Muzna, et al.
Publicado: (2021)

Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)
por: Damy, Thibaud, et al.
Publicado: (2019)

Multimodality imaging of simultaneous occurrence of cardiac transthyretin amyloidosis and cardiac sarcoidosis
por: Elchinova, Elena, et al.
Publicado: (2022)

Dual Aortic Stenosis and Transthyretin Cardiac Amyloidosis: Do We Have Enough Evidence?
por: Gupta, Praveen K.
Publicado: (2022)

How to Identify Transthyretin Cardiac Amyloidosis at an Early Stage
por: Izumiya, Yasuhiro, et al.
Publicado: (2020)

Analysis of disease progression in patients with transthyretin cardiac amyloidosis
por: Gilmore, Julian D, et al.
Publicado: (2015)

Ruptured Bullae: A Case of Transthyretin Cardiac Amyloidosis
por: Dayco, John, et al.
Publicado: (2021)

Transthyretin Cardiac Amyloidosis: A Cardio-Orthopedic Disease
por: Perfetto, Federico, et al.
Publicado: (2022)

Concurrent Waldenstrom Macroglobulinemia and Mutant Transthyretin Cardiac Amyloidosis
por: Qian, Xiaoxiao, et al.
Publicado: (2022)

Progression of echocardiographic parameters and prognosis in transthyretin cardiac amyloidosis
por: Chacko, Liza, et al.
Publicado: (2022)

Restrictive Atrial Dysfunction in Cardiac Amyloidosis: Differences between Immunoglobulin Light Chain and Transthyretin Cardiac Amyloidosis Patients
por: Versteylen, Mathijs O., et al.
Publicado: (2022)

Pilot Study of F18-Florbetapir in the Early Evaluation of Cardiac Amyloidosis
por: Sperry, Brett W., et al.
Publicado: (2021)

Cardiac amyloidosis: diagnostic challenges and recent advancement in the treatment of transthyretin amyloidosis (ATTR)
por: Rahman, Tanvir, et al.
Publicado: (2021)

Spectrum of transthyretin gene mutations and clinical characteristics of Polish patients with cardiac transthyretin amyloidosis
por: Gawor, Monika, et al.
Publicado: (2022)

The Val142Ile transthyretin cardiac amyloidosis: more than an Afro-American pathogenic variant
por: Perfetto, Federico, et al.
Publicado: (2015)

Reply: Dual Aortic Stenosis and Transthyretin Cardiac Amyloidosis: Do We Have Enough Evidence?
por: Singal, Aayush Kumar, et al.
Publicado: (2022)

Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis – Report from the Transthyretin Amyloidosis Outcome Survey (THAOS)
por: Kristen, Arnt V., et al.
Publicado: (2017)

Aging, Aortic Stenosis, and Transthyretin Cardiac Amyloidosis: A Perfect Cardiac Storm?
por: Bokhari, Sabahat, et al.
Publicado: (2021)

Transthyretin Cardiac Amyloidosis and Aortic Stenosis: Connection and Therapeutic Implications
por: Penalver, Jorge, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_slaas0ppe058omtciff0sgqrbh